Habil Khorakiwala – Billionaire

Pharma tycoon Habil Khorakiwala chairs Wockhardt, a pharma company he founded in 1967 after breaking away from his family’s storied retailing empire. Today it is among India’s top generics makers, getting two thirds of its $666 million annual revenue from overseas. Sales in the U.S. have dipped because of continuing quality problems at several of its factories. Younger son Murtaza runs the company. Daughter Zahabiya oversees the hospital arm while another son heads the charitable foundation.

Habil Khorakiwala Net Worth: Habil Khorakiwala is an Indian pharmaceutical tycoon who has a net worth of $710 million. The chairman of generics maker Wockhardt, Mr. Khorakiwala has rejoined the billionaire ranks after a 4-year hiatus. Some three years ago, Wockhardt has endured severe losses due to ambitions expansion plans that pushed the company into red. Thus, its IPO was aborted in 2008, after which Khorakiwala had no other choice but to sell a chunk of his business to Singh brothers for $200 million. However, it was a recent sale of his nutrition business to France’s Danone for $350 million that increased his stock. Now, that he got back to the world of billionaires, he let his daughter Zahabiya, who oversees the health care arm, to expand the Wockhardt hospital chain to smaller towns.

Source:

1. forbes

2. celebritynetworth